Hydrogen peroxide inhibits non-small cell lung cancer cell anoikis through the inhibition of caveolin-1 degradation

American Journal of Physiology - Cell Physiology

Volumn 300, Issue 2, 2011, Pages

  Rungtabnapa, Pimuma ^a   Nimmannit, Ubonthip ^b   Halim, Hasseri ^a   Rojanasakul, Yon ^c   Chanvorachote, Pithi ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

^c WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Detachment; Metastasis; Reactive oxygen species

Indexed keywords

CAVEOLIN 1; HYDROGEN PEROXIDE; HYDROXYL RADICAL; REACTIVE OXYGEN METABOLITE; UBIQUITIN;

ANOIKIS; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; METASTASIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; UBIQUITINATION;

ACETYLCYSTEINE; ANOIKIS; CARCINOMA, NON-SMALL-CELL LUNG; CATALASE; CAVEOLIN 1; CELL LINE, TUMOR; DOWN-REGULATION; FREE RADICAL SCAVENGERS; HUMANS; HYDROGEN PEROXIDE; LUNG NEOPLASMS; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITINATION;

EID: 79251534997     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00249.2010     Document Type: Article

References (59)

1. Albini A, D'Agostini F, Giunciuglio D, Paglieri I, Balansky R, De Flora S. Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetylcysteine. Int J Cancer 29: 121-129, 1995.
2. Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 6: 593-597, 1989. (Pubitemid 19147809)
3. Barja QG, Gil P, Lopez-Torres M. Physiological significance of catalase and glutathione peroxidases, and in vivo peroxidation, in selected tissues of the toad Discoglossus pictus (Amphibia) during acclimation to normobaric hyperoxia. J Comp Physiol [B] 158: 583-590, 1988.
4. Brown NS, Bicknell R. Hypoxia and oxidative stress in breast cancer: oxidative stress - its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res 3: 323-327, 2001.
5. Burdon RH. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 18: 775-794, 1995.
6. Burgermeister E, Xing X, Röcken C, Juhasz M, Chen J, Hiber M, Mair K, Shatz M, Liscovitch M, Schmid RM, Ebert MPA. Differential expression and function of caveolin-1 in human gastric cancer progression. Cancer Res 67: 8519-8526, 2007.
7. Cai J, Jones DP. Mitochondrial redox signaling during apoptosis. J Bioenerg Biomembr 31: 327-334, 1999.
8. Cassoni P, Daniele L, Maldi E, Righi L, Tavaglione V, Novello S, Volante M, Scagliotti GV, Papotti M. Caveolin-1 expression in lung carcinoma varies according to tumor histotype and is acquired de novo in brain metastases. Histopathology 55: 20-27, 2009.
9. Chanvorachote P, Nimmannit U, Lu Y, Talbott S, Jiang BH, Rojanasakul Y. Nitric oxide regulates lung carcinoma cell anoikis through inhibition of ubiquitin-proteasomal degradation of caveolin-1. J Biol Chem 284: 28476-28484, 2009.
10. Chung-man HJ, Zheung S, Comhair SA, Farver C, Erzurm SC. Differential expression of manganese superoxide dismutase and catalase in lung cancer. Cancer Res 61: 8578-8585, 2001.
11. Dunning S, Hannivoort RA, de Boer JF, Buist-Homan M, Faber KN, Moshage H. Superoxide anions and hydrogen peroxide inhibit proliferation of activated rat stellate cells and induce different modes of cell death. Liver Int 29: 922-932, 2009.
12. Engelman JA, Wykoff CC, Yasuhara S, Song KS, Okamoto T, Lisanti MP. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J Biol Chem 272: 16374-16381, 1997. (Pubitemid 27276462)
13. Feinendegen LE. Reactive oxygen species in cell responses to toxic agents. Hum Exp Toxicol 21: 85-90, 2002.
14. Fiucci G, Ravid D, Reich R, Liscovitch M. Caveolin-1 inhibits anchorage- independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells. Oncogene 21: 2365-2375, 2002.
15. Fra AM, Masserini M, Palestini P, Sonnino S, Simons K. A photoreactive derivative of ganglioside GM1 specifically cross-links VIP21- caveolin on the cell surface. FEBS Lett 375: 11-14, 1995.
16. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124: 619-626, 1994.
17. Frisch SM, Screaton RA. Anoikis mechanisms. Curr Opin Cell Biol 13: 555-562, 2001.
18. Garcia-Cardena G, Oh P, Liu J, Schnitzer JE, Sessa WC. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc Natl Acad Sci USA 93: 6448-6453, 1996. (Pubitemid 26230326)
19. Hampton MB, Orrenius S. Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis. FEBS Lett 414: 552-556, 1997.
20. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 100: 57-70, 2000.
21. Hileman OE, Liu J, Albitar M, Keating MJ, Huang P. Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity. Cancer Chemother Pharmacol 53: 209-219, 2004.
22. Ho CC, Huang PH, Huang HY, Chen YH, Yang PC, Hsu SM. Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation. Am J Pathol 161: 1647-1656, 2002.
23. Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, Nakada K, Honma Y, Hayashi J. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320: 661-664, 2008.
24. Jabs T. Reactive oxygen intermediates as mediators of programmed cell death in plants and animals. Biochem Pharmacol 57: 231-245, 1999.
25. Kamata H, Hirata H. Redox regulation of cellular signalling. Cell Signal 11: 1-14, 1999.
26. Koleske AJ, Baltimore D, Lisanti MP. Reduction of caveolin and caveolae in oncogenically transformed cells. Proc Natl Acad Sci USA 92: 1381-1385, 1995.
27. Kundu N, Zhang S, Fulton AM. Sublethal oxidative stress inhibits tumor cell adhesion and enhances experimental metastasis of murine mammary carcinoma. Clin Exp Metastasis 13: 16-22, 1995.
28. Lavie Y, Fiucci G, Liscovitch M. Up-regulation of caveolae and caveolar constituents in multidrug resistant cancer cells. J Biol Chem 273: 32380-32383, 1998.
29. Lavie Y, Liscovitch M. A role for caveolae in multidrug resistance of cancer cells (Abstract). Mol Biol Cell 8: 207, 1997.
30. Li L, Ren CH, Tahir SA, Ren C, Thompson TC. Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A. Mol Cell Biol 23: 9389-9404, 2003. (Pubitemid 37499824)
31. Li S, Couet J, Lisanti MP. Src tyrosine kinases, G alpha subunits and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem 271: 29182-29190, 1996.
32. Li S, Okamoto T, Chun M, Sargiacomo M, Casanova JE, Hansen SH, Nishimoto I, Lisanti MP. Evidence for a regulated interaction of heterotrimeric G proteins with caveolin. J Biol Chem 270: 15693-15701, 1995.
33. Li S, Song KS, Lisanti MP. Expression and characterization of recombinant caveolin. Purification by polyhistidine tagging and cholesteroldependent incorporation into defined lipid membranes. J Biol Chem 271: 568-573, 1996.
34. Lim SD, Sun C, Lambeth JD, Marshall F, Amin M, Chung L, Petros JA, Arnold RS. Increased Nox1 and hydrogen peroxide in prostate cancer. Prostate 62: 200-207, 2004.
35. Maeda H, Hori S, Nishitoh H, Ichijo H, Ogawa O, Kakehi Y, Kakizuka A. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer. Cancer Res 61: 5432-5440, 2001.
36. Martinez E, Domingo P. N-acetylcysteine as chemoprotectant in cancer chemotherapy. Lancet 338: 249, 1991.
37. Misthos P, Katsaragakis S, Milingos N, Kakaris S, Sepsas E, Athasnassiadi K, Theodorou D, Skottis T. Postresectional pulmonary oxidative stress in lung cancer patient. The role of one-lung ventilation. Eur J Cardiothorac Surg 27: 379-383, 2005.
38. Moon KC, Lee GK, Yoo SH, Jeon YK, Chung JH, Han J, Chung DH. Expression of caveolin-1 in pleomorphic carcinoma of the lung is correlated with poor prognosis. Anticancer Res 25: 4631-4637, 2005.
39. Murata M, Peranen J, Schreiner R, Wieland F, Kurzchalia TV, Simons K. VIP21/caveolin is a cholesterol-binding protein. Proc Natl Acad Sci USA 92: 10339-10343, 1995.
40. Nasu Y, Timme TL, Yang G. Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells. Nat Med 4: 1062-1064, 1998.
41. Nishikawa M, Hashida M, Takakura Y. Catalase delivery for inhibiting ROS-mediated tissue injury and tumor metastasis. Adv Drug Deliv Rev 61: 319-326, 2009.
42. Novo E, Marra F, Zamara E, Valfrè di BL, Caligiuri A, Cannito S, Antonaci C, Colombatto S, Pinzani M, Parola M. Dose dependent and divergent effects of superoxide anion on cell death, proliferation, and migration of activated human hepatic stellate cells. Liver 55: 90-97, 2006.
43. Ravid D, Maor S, Werner H, Liscovitch M. Caveolin-1 inhibits anoikis and promotes survival signaling in cancer cells. Adv Enzyme Regul 46: 163-175, 2006.
44. Ravid D, Maor S, Werner H, Liscovitch M. Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by up-regulation of insulin- like growth factor-I receptors and signaling. Oncogene 24: 1338-1347, 2005.
45. Sargiacomo M, Scherer PE, Tang ZL, Kubler E, Song KS, Sanders MC, Lisanti MP. Oligomeric structure of caveolin: implications for caveolae membrane organization. Proc Natl Acad Sci USA 92: 9407-9411, 1995.
46. Shatz M, Liscovitch M. Caveolin-1 and cancer multidrug resistance: coordinate regulation of pro-survival proteins?. Leuk Res 28: 907-908, 2004. (Pubitemid 38953644)
47. Shaul PW, Smart EJ, Robinson LJ, German Z, Yuhanna IS, Ying Y, Anderson RGW, Michel T. Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem 271: 6518-6522, 1996. (Pubitemid 26095467)
48. Song KS, Li S, Okamoto T, Quilliam L, Sargiacomo M, Lisanti MP. Copurification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent free purification of caveolae membranes. J Biol Chem 271: 9690-9697, 1996.
49. Suzuoki M, Miyamoto M, Kato K. Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma. Br J Cancer 87: 1140-1144, 2002.
50. Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51: 794-798, 1991.
51. Tahir SA, Yang G, Ebara S, Timme TL, Satoh T, Li L, Goltsov A, Ittmann M, Morrisett JD, Thompson TC. Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgeninsensitive prostate cancer. Cancer Res 61: 3882-3885, 2001.
52. Temple MD, Perrone GG, Dawes IW. Complex cellular responses to reactive oxygen species. Trends Cell Biol 15: 319-326, 2005.
53. Thompson TC. Metastasis-related genes in prostate cancer: the role of caveolin-1. Cancer Metastasis Rev 17: 439-442, 1999.
54. Veal EA, Day AM, Morgan BA. Hydrogen peroxide sensing and signaling. Mol Cell 26: 1-14, 2007.
55. Wary KK, Mariotti A, Zurzolo C, Giancotti FG. A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchoragedependent cell growth. Cell 94: 625-634, 1998.
56. Wei Y, Yang X, Liu Q, Wilkins JA, Chapman HA. A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling. J Cell Biol 144: 1285-1294, 1999.
57. Williams TM, Lisanti MP. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol 288: C494-C506, 2005.
58. Yang G, Truong LD, Timme TL, Ren C, Wheeler TM, Park SH, Nasu Y, Bangma CH, Kattan MW, Scardino PT, Thompson TC. Elevated expression of caveolin is associated with prostate and breast cancer. Clin Cancer Res 4: 1873-1880, 1998.
59. Yoo SH, Park YS, Kim HR, Sung SW, Kim JH, Shim YS, Lee SD, Choi YL, Kim MK, Chung DH. Expression of caveolin-1 is associated with poor prognosis of patients with squamous cell carcinoma of the lung. Lung Cancer 42: 195-202, 2003.